Welcome to MolDiag-PaCa

1) Rodolosse A, Chalaux E, Adell T, Hag�ge H, Skoudy A, Real FX. PTF-1a/p48 transcription factor couples cell proliferation to cell differentiation in the exocrine pancreas. Gastroenterology 2004; 127:937-949.

2) Aguilar S, Corominas JM, Malats N, Dufresne M, Real FX, Navarro P. Tissue plasminogen activator in murine exocrine pancreas cancer: selective expression in ductal tumors and contribution to cancer progression. Am J Pathol 2004; 165:1129-1139.

3) Real FX. A "catastrophic" hypothesis for pancreas cancer progression. Gastroenterology 2003; 124:1958-1964.

4) Real FX, Malats N, Lesca G, Porta M, Chopin S, Lenoir GM, Sinilnikova O, for the PANKRAS II Study group. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreas cancer. Gut 2002; 50:653-657.

5) Porta M, Malats N, Jariod M, Grimalt JO, Rif� J, Carrato A, Guarner L, Salas A, Santiago-Silva M, Corominas JM, Andreu M, Real FX for the PANKRAS II Study Group. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. Lancet 1999; 354:2125-2129.

6) Vineis P, Malats N, Lang M, d�Errico A, Caporaso N, Cuzick J, Boffetta P. Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications, 1999, ISBN: 9283221486.